8:00 am Registration & Networking Coffee

8:50 am Chair’s Opening Remarks

Overcoming the Regulatory Hurdles to Gain Approval From Governing Bodies

9:00 am Regulatory Perspectives on Developing Pharmaceutical Cannabinoids in the United States

  • Arnold Lippa CEO and Co-Founder, RespireRx Pharmaceuticals

9:30 am Rx and Non-Rx Cannabinoids: A Regulatory Framework for Market Access and Product Quality in Healthcare and Selfcare

10:00 am Panel Discussion: The Industry Approach to Gaining Drug Approval

10:45 am Speed Networking & Morning Refreshments

Determining the Mechanisms Involved in the Endocannabinoid System and Cannabinoid Receptor Biology

11:45 am Understanding the Endocannabinoid System and Cannabinoid Receptor Biology

  • Jahan Marcu CSO , International Research Center on Cannabis and Health

12:15 pm Plant-Derived and Endogenous Cannabinoids: Naturally Different

  • Mauro Maccarrone Professor & Chair of Biochemistry and Molecular Biology, University of Rome

12:45 pm Networking Lunch

1:45 pm Peripherally Restricted CB1 Receptor Blockers for the Treatment of the Metabolic Syndrome

  • Simon Benita Professor & Chairman, Hebrew University of Jerusalem, BioNanoSim Ltd

2:15 pm Panel Discussion: Comparing Whole Plant and Synthetic Cannabinoids and Their Potential in Pharmaceuticals

3:00 pm Afternoon Refreshments & Networking

3:30 pm Panel Discussion: What Targets are Optimal for Different Disease Indications

4:15 pm Intellectual Property Considerations for CDP Pharma

4:45 pm Chair’s Closing Remarks & End of Day One